Related Articles
The anticancer effects of Cucurbitacin I inhibited cell growth of human non‑small cell lung cancer through PI3K/AKT/p70S6K pathway
Cucurbitacin E induces apoptosis of human prostate cancer cells via cofilin-1 and mTORC1
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy Corrigendum in /10.3892/ol.2020.11285
STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
CD5L‑induced activation of autophagy is associated with hepatoprotection in ischemic reperfusion injury via the CD36/ATG7 axis